benchling

ph3Location /h3pZurich, Switzerland /p h3Employment Type /h3pFull time /p h3Location Type /h3pHybrid /p h3Department /h3pCustomer Experience /p pWe are rebuilding biotech for the AI era. /p pWhen a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual,...

ppWe are rebuilding biotech for the AI era.br/When a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected steps. AI has the potential to change this, compressing decades of RD work into years. But that only happens when clean, structured...

We are rebuilding biotech for the AI era.When a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected steps. AI has the potential to change this, compressing decades of R&D work into years. But that only happens when clean, structured scientific...

We are rebuilding biotech for the AI era.When a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected steps. AI has the potential to change this, compressing decades of R&D work into years. But that only happens when clean, structured scientific...

We are rebuilding biotech for the AI era.When a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected steps. AI has the potential to change this, compressing decades of R&D work into years. But that only happens when clean, structured scientific...

We are rebuilding biotech for the AI era.When a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected steps. AI has the potential to change this, compressing decades of R&D work into years. But that only happens when clean, structured scientific...

pBenchling is seeking a Solution Consultant who will lead pre-sales engagements with top biotech customers, translating scientific objectives into actionable Benchling solutions and demonstrations. You’ll work with sales, services, and product teams to map complex RD workflows to data models and AI-enabled workflows. /ppThe role requires hands-on antibody...

Benchling is hiring for Head of EMEA Enterprise Solution Consulting - RD to own the technical, solution, and competitive strategy across Benchling's Enterprise SC-RD in EMEA. This role leads a team of Solution Consultants - RD (Enterprise) and drives revenue by enforcing engagement quality standards.The ideal candidate has presales software leadership...

pBenchling, Inc. is seeking a Technical Account Manager (TAM) based in Zurich to support our EMEA enterprise life science accounts. /ppYou’ll own post-go-live engagements, drive adoption of Benchling’s platform, and partner with CX, Professional Services, and Support to ensure a proactive, high‑quality experience. You will manage complex,...

We are rebuilding biotech for the AI era.When a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected steps. AI has the potential to change this, compressing decades of R&D work into years. But that only happens when clean, structured scientific...

A leading biotech company seeks a Technical Account Manager in Zurich to enhance customer experience with its AI platform. This role involves managing key accounts, ensuring successful product adoption, and requires expertise in Benchling and life sciences. You will collaborate with scientists and stakeholders, driving best practices and addressing project...

We are rebuilding biotech for the AI era.When a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected steps. AI has the potential to change this, compressing decades of R&D work into years. But that only happens when clean, structured scientific...

ppWe are rebuilding biotech for the AI era. /p pWhen a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected steps. AI has the potential to change this, compressing decades of RD work into years. But that only happens when clean, structured...

We are rebuilding biotech for the AI era.When a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected steps. AI has the potential to change this, compressing decades of R&D work into years. But that only happens when clean, structured scientific...

We are rebuilding biotech for the AI era. When a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected steps. AI has the potential to change this, compressing decades of R&D work into years. But that only happens when clean, structured...

We are rebuilding biotech for the AI era.When a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected steps. AI has the potential to change this, compressing decades of RD work into years. But that only happens when clean, structured scientific...

We are rebuilding biotech for the AI era.When a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected steps. AI has the potential to change this, compressing decades of R&D work into years. But that only happens when clean, structured scientific...

ppWe are rebuilding biotech for the AI era. /p pWhen a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected steps. AI has the potential to change this, compressing decades of RD work into years. But that only happens when clean, structured...

ppWe are rebuilding biotech for the AI era. /p pWhen a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected steps. AI has the potential to change this, compressing decades of RD work into years. But that only happens when clean, structured...

We are rebuilding biotech for the AI era. When a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected steps. AI has the potential to change this, compressing decades of R&D work into years. But that only happens when clean, structured...